Improvement in HDL Function in Early Rheumatoid Arthritis Patients Treated with Methotrexate Monotherapy or Combination Therapy in the TEAR Trial

OBJECTIVE: Abnormal function of high density lipoprotein (HDL) has been implicated as a potential mechanism for the increased cardiovascular disease (CVD) in patients with rheumatoid arthritis. The current work evaluated changes in HDL function and HDL-associated proteins over two years of follow-up...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Arthritis Rheumatol
Päätekijät: Charles-Schoeman, Christina, Lee, Yuen Yin, Shahbazian, Ani, Wang, Xiaoyan, Elashoff, David, Curtis, Jeffrey R, Navarro-Millán, Iris, Yang, Shuo, Chen, Lang, Cofield, Stacey S, Moreland, Larry W, Paulus, Harold, O’Dell, James, Bathon, Joan, Bridges, S. Louis, Reddy, Srinivasa T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5195879/
https://ncbi.nlm.nih.gov/pubmed/27483410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39833
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia